Association of HA130/KHA80 hemoperfusion combined with hemodialysis with survival outcomes in patients receiving maintenance hemodialysis: a time-dependent and propensity score-matched analysis
Yan Liu, Wei Gang, Wei Chen, Limei Yang, Rui Dong, Zhiyong Guo · 2026
Read Association of HA130/KHA80 hemoperfusion combined with hemodialysis with survival outcomes in patients receiving maintenance hemodialysis: a time-dependent and propensity score-matched analysis by Yan Liu, Wei Gang, Wei Chen, Limei Yang, Rui Dong, Zhiyong Guo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13411991.txt.
Description
Yan Liu and co-authors examine, in a 2026 retrospective cohort study from Shanghai Changhai Hospital, whether adding hemoperfusion to regular dialysis helps patients live longer. People on maintenance dialysis die at high rates, most often from cardiovascular disease. The study followed 640 patients with end-stage kidney disease treated between 2015 and 2023, of whom 221 also received hemoperfusion sessions.
Over follow-up, 348 patients died, about a third of them from cardiovascular causes. Models that treated hemoperfusion as a time-varying exposure linked the added therapy to a lower risk of death, with hazard ratios near 0.7. A matched comparison of 173 patients per group pointed the same way, supporting a survival benefit worth testing prospectively.
Catalog record
| CREATOR | Yan Liu, Wei Gang, Wei Chen, Limei Yang, Rui Dong, Zhiyong Guo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47731 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |